S&P 500   3,699.12 (+0.88%)
DOW   30,218.26 (+0.83%)
QQQ   305.52 (+0.41%)
AAPL   122.25 (-0.56%)
MSFT   214.36 (+0.06%)
FB   279.70 (-0.76%)
GOOGL   1,823.76 (+0.11%)
AMZN   3,162.58 (-0.76%)
TSLA   599.04 (+0.95%)
NVDA   542.33 (+1.21%)
BABA   267.25 (+0.13%)
CGC   28.59 (-0.14%)
GE   10.88 (+2.64%)
MU   73.34 (+4.92%)
AMD   94.04 (+1.87%)
T   29.54 (+1.06%)
NIO   43.04 (-5.09%)
F   9.34 (+1.41%)
ACB   10.89 (-3.11%)
BA   232.71 (-1.89%)
NFLX   498.31 (+0.16%)
GILD   61.56 (+1.15%)
DIS   154.14 (+0.59%)
S&P 500   3,699.12 (+0.88%)
DOW   30,218.26 (+0.83%)
QQQ   305.52 (+0.41%)
AAPL   122.25 (-0.56%)
MSFT   214.36 (+0.06%)
FB   279.70 (-0.76%)
GOOGL   1,823.76 (+0.11%)
AMZN   3,162.58 (-0.76%)
TSLA   599.04 (+0.95%)
NVDA   542.33 (+1.21%)
BABA   267.25 (+0.13%)
CGC   28.59 (-0.14%)
GE   10.88 (+2.64%)
MU   73.34 (+4.92%)
AMD   94.04 (+1.87%)
T   29.54 (+1.06%)
NIO   43.04 (-5.09%)
F   9.34 (+1.41%)
ACB   10.89 (-3.11%)
BA   232.71 (-1.89%)
NFLX   498.31 (+0.16%)
GILD   61.56 (+1.15%)
DIS   154.14 (+0.59%)
S&P 500   3,699.12 (+0.88%)
DOW   30,218.26 (+0.83%)
QQQ   305.52 (+0.41%)
AAPL   122.25 (-0.56%)
MSFT   214.36 (+0.06%)
FB   279.70 (-0.76%)
GOOGL   1,823.76 (+0.11%)
AMZN   3,162.58 (-0.76%)
TSLA   599.04 (+0.95%)
NVDA   542.33 (+1.21%)
BABA   267.25 (+0.13%)
CGC   28.59 (-0.14%)
GE   10.88 (+2.64%)
MU   73.34 (+4.92%)
AMD   94.04 (+1.87%)
T   29.54 (+1.06%)
NIO   43.04 (-5.09%)
F   9.34 (+1.41%)
ACB   10.89 (-3.11%)
BA   232.71 (-1.89%)
NFLX   498.31 (+0.16%)
GILD   61.56 (+1.15%)
DIS   154.14 (+0.59%)
S&P 500   3,699.12 (+0.88%)
DOW   30,218.26 (+0.83%)
QQQ   305.52 (+0.41%)
AAPL   122.25 (-0.56%)
MSFT   214.36 (+0.06%)
FB   279.70 (-0.76%)
GOOGL   1,823.76 (+0.11%)
AMZN   3,162.58 (-0.76%)
TSLA   599.04 (+0.95%)
NVDA   542.33 (+1.21%)
BABA   267.25 (+0.13%)
CGC   28.59 (-0.14%)
GE   10.88 (+2.64%)
MU   73.34 (+4.92%)
AMD   94.04 (+1.87%)
T   29.54 (+1.06%)
NIO   43.04 (-5.09%)
F   9.34 (+1.41%)
ACB   10.89 (-3.11%)
BA   232.71 (-1.89%)
NFLX   498.31 (+0.16%)
GILD   61.56 (+1.15%)
DIS   154.14 (+0.59%)
Log in
NYSE:BHVN

Biohaven Pharmaceutical Short Interest Ratio and Short Volume

$88.36
+1.33 (+1.53 %)
(As of 12/4/2020 12:00 AM ET)
Add
Compare
Today's Range
$86.34
Now: $88.36
$89.48
50-Day Range
$77.00
MA: $85.88
$98.24
52-Week Range
$26.56
Now: $88.36
$100.77
Volume352,064 shs
Average Volume783,055 shs
Market Capitalization$5.30 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.11

Short Interest

Biohaven Pharmaceutical (NYSE:BHVN) Short Interest Data

Current Short Volume:7,190,000 shares
Previous Short Volume:8,820,000 shares
Change Vs. Previous Month:-18.48%
Dollar Volume Sold Short:$639.55 million
Short Interest Ratio / Days to Cover:13.0
Last Record Date:November, 15 2020
Outstanding Shares:51,500,000 shares
Short Percent of Float:0.00%
Today's Trading Volume:352,064 shares
Average Trading Volume:783,055 shares
Today's Volume Vs. Average:-55.04%



Biohaven Pharmaceutical (NYSE:BHVN) Short Interest History

DateShares Sold ShortDollar Volume Sold ShortPercentage ChangePercentage FloatDays to CoverPrice on Record Date
11/15/20207,190,000 $639.55 million -18.5%0.0%12.9$88.95
10/30/20208,820,000 $833.58 million -1.8%0.0%17.5$94.51
10/15/20208,980,000 $709.87 million -7.0%0.0%18.1$79.05
9/30/20209,660,000 $748.84 million 0.9%0.0%19.2$77.52
9/15/20209,570,000 $599.94 million 0.6%0.0%17.5$62.69
8/31/20209,510,000 $587.43 million 2.0%0.0%15$61.77
8/14/20209,320,000 $575.98 million 0.4%0.0%13$61.80
7/31/20209,280,000 $587.33 million -5.7%18.4%12.2$63.29
7/15/20209,840,000 $630.15 million 4.0%19.5%12.6$64.04
6/30/20209,460,000 $658.89 million -7.3%18.7%10.9$69.65
6/15/202010,200,000 $739.60 million -1.1%20.4%10.7$72.51
5/29/202010,310,000 $722.11 million -2.5%20.6%11.1$70.04
5/15/202010,570,000 $660.31 million 1.7%21.1%11$62.47
4/30/202010,390,000 $624.54 million 1.2%20.7%10.2$60.11
4/15/202010,270,000 $512.99 million 8.8%20.5%9.3$49.95
3/31/20209,440,000 $443.40 million 10.3%18.9%8.6$46.97
3/13/20208,559,700 $310.20 million 3.1%17.9%9.2$36.24
2/28/20208,300,000 $243.52 million 2.6%16.7%8.9$29.34
2/14/20208,090,000 $356.36 million 1.5%16.6%8.9$44.05
1/31/20207,970,000 $355.70 million 23.0%17.0%8.8$44.63
1/15/20206,480,000 $292.70 million 4.0%15.1%9.5$45.17
12/31/20196,230,000 $339.54 million -6.9%14.5%10.1$54.50
8/15/20195,592,900 $217.23 million 6.1%17.2%5.5$38.84

Biohaven Pharmaceutical (NYSE:BHVN) Short Interest FAQ

speech bubbles
speech bubbles











What is Biohaven Pharmaceutical's current short interest?

Short interest is the volume of Biohaven Pharmaceutical shares that have been sold short but have not yet been closed out or covered. As of November 15th, investors have sold 7,190,000 shares of BHVN short. 0.00% of Biohaven Pharmaceutical's shares are currently sold short. View details.

What is a good short interest ratio for Biohaven Pharmaceutical?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. Biohaven Pharmaceutical currently has a short interest ratio of 13.0.

Is Biohaven Pharmaceutical's short interest increasing or decreasing?

Biohaven Pharmaceutical saw a decline in short interest in November. As of November 15th, there was short interest totaling 7,190,000 shares, a decline of 18.5% from the previous total of 8,820,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Biohaven Pharmaceutical's short interest compare to its competitors?

0.00% of Biohaven Pharmaceutical's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Biohaven Pharmaceutical: BeiGene, Ltd. (0.00%), Horizon Therapeutics Public Limited (0.00%), Ono Pharmaceutical Co., Ltd. (0.00%), Catalent, Inc. (0.00%), Alnylam Pharmaceuticals, Inc. (0.00%), BioMarin Pharmaceutical Inc. (0.00%), Elanco Animal Health Incorporated (0.00%), Grifols, S.A. (1.11%), Sarepta Therapeutics, Inc. (0.00%), and Mirati Therapeutics, Inc. (0.00%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.96 billion), Aon Plc ($3.87 billion), Moderna, Inc. ($3.77 billion), Analog Devices, Inc. ($3.62 billion), Snap Inc. ($3.05 billion), The Clorox Company ($2.80 billion), The Kroger Co. ($2.11 billion), International Flavors & Fragrances Inc. ($1.98 billion), Expedia Group, Inc. ($1.95 billion), and Peloton Interactive, Inc. ($1.78 billion). View all of the most shorted stocks.

What does it mean to sell short Biohaven Pharmaceutical stock?

Short selling BHVN is an investing strategy that aims to generate trading profit from Biohaven Pharmaceutical as its price is falling. Biohaven Pharmaceutical's stock is trading up $1.33 today. To short Biohaven Pharmaceutical stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that Biohaven Pharmaceutical will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Biohaven Pharmaceutical?

A short squeeze for Biohaven Pharmaceutical occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of BHVN, which in turn drives the price of the stock up even further.

How often is Biohaven Pharmaceutical's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BHVN, twice per month. The most recent reporting period available is November, 15 2020.


This page was last updated on 12/4/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.